title: Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen.
authors.forename: D A
authors.initials: DA
authors.lastname: Scudiero
authors.forename: A
authors.initials: A
authors.lastname: Monks
authors.forename: E A
authors.initials: EA
authors.lastname: Sausville
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000032:analysis; D000230:Adenocarcinoma / Q000473:pathology*; D001943:Breast Neoplasms / Q000473:pathology*; D016172:DNA Fingerprinting; D004273:DNA, Neoplasm / Q000235:genetics; D004317:Doxorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D005260:Female; D006801:Humans; D009316:National Institutes of Health (U.S.); D009363:Neoplasm Proteins / Q000032:analysis; D009376:Neoplasms, Hormone-Dependent / Q000473:pathology*; D009626:Terminology as Topic; D014407:Tumor Cells, Cultured; D014481:United States
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D004317:Doxorubicin